CNQ

What Canadian Natural Resources (CNQ) Investors Need to Know

More and more people are talking about Canadian Natural Resources over the last few weeks. Is it worth buying the Oil & Gas Drilling stock at a price of $62.3? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • CNQ has an average analyst rating of buy and is -16.2% away from its mean target price of $74.35 per share

  • Its trailing earnings per share (EPS) is $4.76

  • Canadian Natural Resources has a trailing 12 month Price to Earnings (P/E) ratio of 13.1 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $6.89 and its forward P/E ratio is 9.0

  • The company has a Price to Book (P/B) ratio of 1.71 in contrast to the S&P 500's average ratio of 2.95

  • Canadian Natural Resources is part of the Energy sector, which has an average P/E ratio of 8.53 and an average P/B of 1.78

  • CNQ has reported YOY quarterly earnings growth of -14.5% and gross profit margins of 0.5%

  • The company has a free cash flow of $6.69 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Canadian Natural Resources Limited acquires, explores for, develops, produces, markets, and sells crude oil, natural gas, and natural gas liquids (NGLs). The company offers light and medium crude oil, primary heavy crude oil, Pelican Lake heavy crude oil, bitumen (thermal oil), and synthetic crude oil (SCO). The company's midstream assets include two pipeline systems; and a 50% working interest in an 84-megawatt cogeneration plant at Primrose. It operates primarily in Western Canada; the United Kingdom portion of the North Sea; and Offshore Africa. The company was formerly known as AEX Minerals Corporation and changed its name to Canadian Natural Resources Limited in December 1975. Canadian Natural Resources Limited was incorporated in 1973 and is headquartered in Calgary, Canada.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS